David Peinsipp

David Peinsipp

Partner
Full contact info

I believe corporate law can be as creative and disruptive as the clients I represent.

Passions

IPOs

Literature

Gator football

Experience

Hootsuite to Acquire Talkwalker

April 8, 2024

Cooley advised Hootsuite, a global leader in social media management, on its definitive agreement to acquire Talkwalker, a top artificial intelligence-powered social listening solution.

Read more

Related contacts

Jamie Leigh
Partner, San Francisco
Bill Roegge
Partner, New York
David Peinsipp
Partner, San Francisco
Nathan Baum
Associate, New York
Yoana Setzer
Associate, New York
Annie Froehlich
Partner, Washington, DC
Len Jacoby
Partner, New York
Eileen Marshall
Partner, Washington, DC
Howard Morse
Partner, Washington, DC
Gerard O'Shea
Partner, New York
Nyron J. Persaud
Partner, New York
Lei Shen
Partner, Chicago
Chris Stack
Partner, London
David Burns
Special Counsel, Washington, DC
Dillon Martinson
Special Counsel, Washington, DC
Stella Sarma
Special Counsel, Brussels
Grant Schweikert
Special Counsel, Washington, DC
Bryan Berman
Special Counsel, Colorado
Cara Buchicchio
Associate, New York
Umer Chaudhry
Associate, Washington, DC
Liza Cotter
Associate, Boston
Sharon Davidov
Associate, New York
Megan Drill
Associate, San Diego
Athina Gaki
Associate, Brussels
Michael Gladstone
Associate, New York
Erin Hilliard
Associate, San Francisco
Rachel F. Katz
Associate, New York
Chris Lynn
Associate, London
Daniel Millard
Associate, London
Edward (Teddy) Nimetz
Associate, New York
Nick Perez
Associate, Washington, DC
Patrick Sharma
Associate, Los Angeles Santa Monica
Leo Spicer-Phelps
Associate, London
Rubin Waranch
Associate, Colorado
Patricia Myers
Paralegal Specialist, Colorado

Related Practices & Industries

Viking Therapeutics Announces $632.5 Million Public Offering of Common Stock

March 4, 2024

Cooley advised the underwriters of Viking Therapeutics – a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders – on its $632.5 million public offering of common stock.

Read more

Related contacts

Denny Won
Partner, San Francisco
Kristin VanderPas
Partner, San Francisco
Charlie Kim
Partner, San Diego
David Peinsipp
Partner, San Francisco
Valerie Sapozhnikova
Associate, Los Angeles Downtown
Madison (JJ) Meng
Associate, San Francisco
Peter A. Haddad
Associate, San Diego
Natasha Leskovsek
Of Counsel, Washington, DC
Phil Mitchell
Partner, New York
Wyatt Kernell
Associate, New York
Madhuri Roy
Partner, Palo Alto
Randy Sabett
Special Counsel, Washington, DC
Rebecca Ross
Special Counsel, Washington, DC
Xander Lee
Partner, Los Angeles Santa Monica

Related Practices & Industries

CG Oncology Announces Upsized $437 Million IPO

January 29, 2024

Cooley advised the underwriters of CG Oncology, a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer, on the pricing of its upsized $437 million initial public offering. Partners Charlie Kim, Denny Won, Kristin VanderPas and David Peinsipp led the Cooley team advising the underwriters.

Related contacts

Charlie Kim
Partner, San Diego
Denny Won
Partner, San Francisco
Kristin VanderPas
Partner, San Francisco
David Peinsipp
Partner, San Francisco

Related Practices & Industries

Carmot Therapeutics Enters Definitive Merger Agreement With Roche

December 3, 2023

Cooley advised Carmot Therapeutics, a clinical-stage biotechnology company dedicated to developing life-changing therapeutics for people living with metabolic diseases including obesity and diabetes, on its definitive merger agreement in which Roche will acquire Carmot.

Read more

Related contacts

Jamie Leigh
Partner, San Francisco
Ben Beerle
Partner, San Francisco
Charity Williams
Partner, San Diego
David Peinsipp
Partner, San Francisco
Kristin VanderPas
Partner, San Francisco
Lauren Creel
Partner, Palo Alto
Howard Morse
Partner, Washington, DC
Xander Lee
Partner, Los Angeles Santa Monica
Kathleen O'Neill
Partner, Washington, DC
Ross Eberly
Partner, Los Angeles Santa Monica
Barbara Mirza
Partner, Los Angeles Santa Monica
TJ Graham
Partner, Palo Alto
Christopher Kimball
Partner, Washington, DC
Tracy Rubin
Partner, Palo Alto
Phil Mitchell
Partner, New York
Charlie Kim
Partner, San Diego
Natasha Leskovsek
Of Counsel, Washington, DC
Christine Graham
Special Counsel, London
Stella Sarma
Special Counsel, Brussels
J. Brian Stalter
Special Counsel, New York
Jennifer Shanley
Special Counsel, New York
Grant Schweikert
Special Counsel, Washington, DC
Kristopher Kleiner
Special Counsel, Colorado
Dani Nazemian
Special Counsel, San Diego
Annie Froehlich
Partner, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Stacey A. Bradford
Special Counsel, Washington, DC
Sangitha Palaniappa
Associate, Palo Alto
Tyler McClure
Associate, San Francisco
Rubin Waranch
Associate, Colorado
Melissa Meza
Associate, San Diego
Jameson Davis
Associate, Boston
Alexander Ellebracht
Associate, Palo Alto
Mor Agam
Associate, New York
Athina Gaki
Associate, Brussels
Andy Zachrich
Associate, San Diego
Dionne A. Thomas
Associate, San Diego
Umer Chaudhry
Associate, Washington, DC
Jane Jun
Associate, Palo Alto
Samara Zaifman
Associate, Palo Alto
Carly E. Gibbons
Associate, Chicago
Claire Norman
Associate, Palo Alto
Anitha Anne
Associate, San Francisco
Kristina Krasnikova
Associate, Palo Alto
Patricia Myers
Paralegal Specialist, Colorado
Loraine Torres
Paralegal Specialist, Colorado
Hitesh Patel
eDiscovery Attorney, Washington, DC

Related Practices & Industries

Neumora Therapeutics – $250.1 Million IPO

September 15, 2023

Cooley advised the underwriters on the $250.1 million initial public offering of Neumora Therapeutics, a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed.

Read more

Related contacts

Charlie Kim
Partner, San Diego
Kristin VanderPas
Partner, San Francisco
David Peinsipp
Partner, San Francisco
Denny Won
Partner, San Francisco
Grady Chang
Associate, Los Angeles Santa Monica
Madison (JJ) Meng
Associate, San Francisco
Kyle Huh
Associate, Palo Alto
Peter A. Haddad
Associate, San Diego
Heidi Ausman
Senior Paralegal, San Diego
Lila Hope
Partner, Palo Alto
Natasha Leskovsek
Of Counsel, Washington, DC
Mika Reiner Mayer
Partner, Palo Alto
Barbara Mirza
Partner, Los Angeles Santa Monica
Phil Mitchell
Partner, New York
Jennifer Raab
Partner, Palo Alto
Madhuri Roy
Partner, Palo Alto
Erica Russell
Associate, San Francisco
Randy Sabett
Special Counsel, Washington, DC
Jennifer Shanley
Special Counsel, New York
Karen Tsai
Special Counsel, Washington, DC
Francis Wheeler
Partner, Colorado
Mark Windfeld-Hansen
Senior Counsel, Palo Alto

Related Practices & Industries

View more

Admissions & credentials

California

Not admitted to practice in Florida

Rankings & accolades

Chambers USA: Capital Markets: Debt & Equity – California (2021 – 2023)

Chambers USA: Capital Markets: Debt & Equity: Western United States – Nationwide (2020 – 2023)

Chambers USA: SPACs – Nationwide (2023)

Daily Journal: California Lawyer Attorneys of the Year Awards (2020); Top 100 Lawyers in California (2019 – 2020); Top 20 Under 40 (2014)

IFLR1000 US: Lawyer of the Year – Capital Markets (2020)

Law 360: Capital Markets MVP (2019)

The Legal 500 US: Leading Lawyer in Capital Markets: Equity Offerings (2020 – 2023)

The Legal 500 US: Next Generation Lawyer in Capital Markets: Equity (2019)

Memberships & affiliations

American Bar Association

The Bar Association of San Francisco

Representative issuers:

Dave has represented companies/investment banks on capital market transactions involving issuers across industries, such as: 10X Genomics, 4D Molecular Therapeutics, Accelerate Diagnostics, Acutus Medical, Aerohive Networks, Alteryx, ALX Oncology, Ambarella, Amyris, Applied Molecular Transport, Anthera Pharmaceuticals, Apigee, Applied Molecular Transport, Annexon, Apptio, Arcadia Biosciences, Arcutis Biotherapeutics, Aridis Pharmaceuticals, ARMO BioSciences, Ascendis Pharma, ASLAN Pharmaceuticals, Atlassian, Athira Pharma, Audentes Therapeutics, Cision, Crinetics Pharmaceuticals, Dermira, DocuSign, Doximity, Dutch Bros., EHang, Eidos Therapeutics, Expensify, Fantex, FIGS, FireEye, Five Prime Therapeutics, Global Blood Therapeutics, Gossamer Bio, Graphite Bio, Gritstone Oncology, Guardant Health, Health Catalyst, HealthEquity, Hyperion Therapeutics, IGM Biosciences, Ignyta, Immune Design, Inhibrx, Invitae, Kinnate Biopharma, Kodiak Sciences, LinkedIn, Livongo Health, Lulu’s Fashion Lounge, Lyell Immunopharma, MINDBODY, Mobile Iron, NantKwest, Nanthealth, NerdWallet, New Relic, Olema Pharmaceuticals, Ooma, Opendoor Labs, Otonomy, Pliant Therapeutics, Principia Biopharma, PROCEPT BioRobotics, ProNai, ProQR Therapeutics, PROS Holdings, Rigel Pharmaceuticals, Qualtrics, Root, Sana Biotechnology, Satsuma Pharmaceuticals, Savara, Shockwave Medical, Sierra Oncology, Smart Share Global, Snap, Stitch Fix, Sutro Biopharma, Sweetgreen, Syndax Pharmaceuticals, Tableau Software, Taiwan Liposome Company, Treace Medical Concepts, Tricida, Trivascular, Twilio, Uber, Ventyx, ViewRay, Warby Parker, Wish, Xenon Pharmaceuticals, Xometry, Yelp, Zendesk, Zscaler, Zymeworks, Zynga.